All In MedTech

Device Trial Radar · NCT04431544

AcQMap® US Registry of Procedural and Long-term Clinical Outcomes (Discover-US)

Last checked: Nov 20, 2026Latest source record: Nov 13, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

513

Actual

Start

Sep 29, 2020

Primary completion

Nov 8, 2023

Study completion Nov 8, 2023

Sponsor

Lead sponsor
Acutus MedicalNot on our public-company list
Sponsor type
Industry
First posted
Jun 16, 2020

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

AcQMap Registry is an observation study

Conditions

  • Ablation of Arrhythmia's

Interventions

  • AcQMap SystemDevice

    To evaluate procedural and long-term outcomes when using the diagnostic AcQMap System as an imaging and mapping system for ablation of arrhythmias in accordance with the Instructions for Use (IFU).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Procedural Ablation OutcomesTime frame: 12 hours

Locations

25 sites in 1 country. Site status is shown where the registry gives one.

  • Grandview Medical Group Research

    Birmingham, Alabama

24 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.